Interventional Cardiology Devices Market

Interventional Cardiology Devices Market worth $20.8 billion by 2022

The global Interventional Cardiology Devices Market was valued at USD 14.5 billion in 2017 and is estimated to grow at a CAGR of 7.5% during the forecast period, to reach USD 20.8 billion by 2022. The rising incidence of cardiovascular diseases and technological advancements in interventional cardiology devices are the major factors that are driving the growth of this market. Moreover, the emergence of bioabsorbable stents and the increasing healthcare expenditure in emerging countries are some of the other major factors that are expected to offer opportunities for market growth in the coming years.

Browse 156 market data Tables and 40 Figures spread through 179 Pages and in-depth TOC on "Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) - Global Forecast to 2022"

View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html

Drug-eluting stents accounted for the largest share of the angioplasty stents market in 2017

The angioplasty stents market is segmented into bare-metal stents, drug-eluting stents, and bioabsorbable stents. In 2017, drug-eluting stents dominated the angioplasty stents market as they provide better clinical outcomes as compared to bare-metal stents. Also, the widespread availability of drug-eluting stents across the globe is a major factor supporting the growth of this market segment.

The drug-eluting balloons segment is expected to grow at the highest CAGR in the angioplasty balloons market

The angioplasty balloons market is segmented into old/normal balloons, cutting & scoring balloons, and drug-eluting balloons. Although the old/normal balloons segment dominated this market in 2017, the drug-eluting balloons segment is estimated to grow at the highest CAGR during the forecast period. The high growth of this segment can majorly be attributed to the advantages offered by drug-eluting balloons (overcoming complications, such as late thrombosis, associated with drug-eluting stent procedures) and the approval of an increasing number of drug-eluting balloons in the market.

North America is the largest regional market for interventional cardiology devices

Currently, North America is the largest regional market for interventional cardiology devices, and this trend is expected to continue during the forecast period. This can majorly be attributed to factors such as the high and growing prevalence of cardiovascular diseases, high adoption of advanced interventional cardiology devices, and the presence of an advanced healthcare system in the US and Canada.

The key players operating in the interventional cardiology devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany).

Don’t miss out on business opportunities in Interventional Cardiology Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 3456
PR Published ON
7/26/2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Interventional Cardiology Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home